Next Article in Journal
Safety Analysis of Motorcycle Crashes in Seoul Metropolitan Area, South Korea: An Application of Nonlinear Optimal Scaling Methods
Next Article in Special Issue
Statins and Cardiovascular Disease Outcomes in Chronic Kidney Disease: Reaffirmation vs. Repudiation
Previous Article in Journal
Challenges Facing Home-Based Caregivers in the Management of Health Care Risk Waste
Previous Article in Special Issue
Knowledge Management for Fostering Biostatistical Collaboration within a Research Network: The RTRN Case Study
Open AccessCommunication

The Role of Vitamin D and Oxidative Stress in Chronic Kidney Disease

1
Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90024, USA
2
Department of Medicine, Harvard Medical School, Harvard University, Boston, MA 02138, USA
3
RCMI Translational Research Network Data Coordinating Center, College of Science, Engineering and Technology, Jackson State University, Jackson, MS 39217, USA
4
Department of Family Medicine, Morehouse School of Medicine, Atlanta, GA 30310, USA
5
Department of Medicine, College of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2018, 15(12), 2701; https://doi.org/10.3390/ijerph15122701
Received: 19 October 2018 / Revised: 19 November 2018 / Accepted: 23 November 2018 / Published: 30 November 2018
Chronic kidney disease (CKD) is a major non-communicable disease associated with high rates of premature morbidity and mortality. The prevalence of hypovitaminosis D (deficiency of 25(OH)D or 25D) is greater in racial/ethnic minorities and in patients with CKD than the general population. Low 25D is associated with bone and mineral disorders as well as immune, cardiometabolic and cardiovascular (CV) diseases. Thus, it has been suggested that low 25D contributes to the poor outcomes in patients with CKD. The prevalence of hypovitaminosis D rises progressively with advancing severity of kidney disease with over 30% of patients with CKD stage 3 and 70% patients with CKD stage 5 estimated to have low levels of 25D. This report describes several of the abnormal physiologic and counter-regulatory actions related to low 25D in CKD such as those in oxidative stress and inflammatory systems, and some of the preclinical and clinical evidence, or lack thereof, of normalizing serum 25D levels to improve outcomes in patients with CKD, and especially for the high risk subset of racial/ethnic minorities who suffer from higher rates of advanced CKD and hypovitaminosis D. View Full-Text
Keywords: vitamin D; oxidative stress; kidney disease; disparities vitamin D; oxidative stress; kidney disease; disparities
Show Figures

Figure 1

MDPI and ACS Style

Norris, K.C.; Olabisi, O.; Barnett, M.E.; Meng, Y.-X.; Martins, D.; Obialo, C.; Lee, J.E.; Nicholas, S.B. The Role of Vitamin D and Oxidative Stress in Chronic Kidney Disease. Int. J. Environ. Res. Public Health 2018, 15, 2701.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop